On January 28, Senator Dick Durbin (D-IL) reintroduced the American Cures Act (S. 289). The bill would support research at the National Institutes of Health, the Centers for Disease Control and Prevention, the Department of Defense Health Program, and the Veterans Medical and Prosthetics Research Program. The measure is designed to set a steady growth rate in federal appropriations for biomedical research conducted at these agencies. Annually, the bill would increase funding for each agency and program at a rate of GDP-indexed inflation plus five percent. The “steady, long-term investment” provided by the legislation, if enacted, “would allow the agencies to plan and manage strategic growth while maximizing efficiencies.” The measure is cosponsored by Senators Sherrod Brown (D-OH), Amy Klobuchar (D-MN), Barbara Boxer (D-CA), Edward J. Markey (D-MA), Ben Cardin (D-MD), Al Franken (D-MN), and Bob Casey (D-PA).